Long Term Forecasts. Not less than six months prior to the actual date of First Commercial Sale of Licensed Products in the Territory (the "Startup Date"), Synthelabo shall provide PRAECIS with a non-binding forecast (a "Long-Term Forecast") of its total good-faith estimate of its requirements for Licensed Products during the first three annual periods following the Startup Date, with such projected requirements to be broken down on a quarter-by-quarter basis for each such annual period. Not later than the first December 1 following the Startup Date and, thereafter, on each anniversary of such date, Synthelabo shall provide PRAECIS with a revised Long-Term Forecast covering the three calendar years following the year in which such revised Long-Term Forecast is provided, with such projected requirements to be broken down on a quarter-by-quarter basis for each such calendar year.
Appears in 3 contracts
Sources: License Agreement (Praecis Pharmaceuticals Inc), License Agreement (Praecis Pharmaceuticals Inc), License Agreement (Praecis Pharmaceuticals Inc)